Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ayurcann Holdings is a Canadian-based cannabis extraction and manufacturing company that specializes in providing post-harvest solutions to licensed producers. The company operates a large-scale facility in Ontario, focusing on the production of high-quality cannabinoid oils, distillates, and consumer-ready products such as vapes and topicals. Ayurcann serves both the medical and recreational markets through its own house brands and B2B manufacturing partnerships. By utilizing advanced CO2 extraction and refinement technologies, the company ensures high purity and potency in its product offerings. Their business strategy emphasizes scalability and cost-efficiency in the rapidly evolving cannabis sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ayurcann Holdings.